<DOC>
	<DOCNO>NCT02117986</DOCNO>
	<brief_summary>The study hypothesis load dose intravenous colistin ( 6 million international unit ) associate great clinical microbiological efficacy , reduce mortality critically ill patient infect multidrug resistant Gram- negative bacillus , compare scheme without load dose .</brief_summary>
	<brief_title>Efficacy Mortality Loading Dose Colistin Critical Ill Patients</brief_title>
	<detailed_description>It prospective , multicenter , randomize , control study evaluate scheme without load dose 6 million international unit colistin , follow maintenance dose 3 million international unit every 8 hour intravenous . The study conduct 3 hospital Chile , critically patient present infection multidrug Gram-negative bacteria require treated colistin least 48 hour . The objective study : evaluate clinical microbiological response , mortality .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Negative Bacterial Infections</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>patient hospitalize critical care unit patient infected multi drug resistant Gram negative bacteria susceptibly colistin source infection : blood , respiratory , intra abdominal urinary pregnant breastfeeding patient patient history hypersensitivity colistin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>critically ill patient</keyword>
	<keyword>colistin dose</keyword>
	<keyword>multidrug resistant bacteria</keyword>
</DOC>